abstract |
The specification describes the use of a 19-nor cholane steroid as depicted above in a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e.g. a 19-nor cholane steroid, or a pharmaceutical composition containing a vomeropherin. |